BAXTER INTERNATIONAL INC. Most Important Performance Measures
The measures each proxy statement lists as most important for linking pay to performance (Item 402(v) tabular list), as tagged, newest proxy first.
- 2023-03-23: Measure Earnings Per Share.
- 2023-03-23: Measure Free Cash Flow.
- 2023-03-23: Measure Net Sales.
- 2023-03-23: Measure ROIC.
| Proxy filed | Measure |
|---|---|
| 2023-03-23 | Earnings Per Share |
| 2023-03-23 | Free Cash Flow |
| 2023-03-23 | Net Sales |
| 2023-03-23 | ROIC |
| 2023-03-23 | TSR |
| 2024-03-25 | Net Sales |
| 2024-03-25 | Earnings Per Share |
| 2024-03-25 | Free Cash Flow |
| 2024-03-25 | ROIC |
| 2024-03-25 | Relative TSR |
| 2025-03-25 | net sales |
| 2025-03-25 | Net Sales |
| 2025-03-25 | Adjusted Earnings Per Share |
| 2025-03-25 | Free Cash Flow |
| 2025-03-25 | ROIC |
| 2025-03-25 | Relative TSR |
| 2026-03-23 | Net Sales From Continuing Operations |
| 2026-03-23 | Adjusted Earnings Per Share From Continuing Operations |
| 2026-03-23 | Free Cash Flow From Continuing Operations |
| 2026-03-23 | ROIC |
| 2026-03-23 | Relative TSR |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |